Open Access 01-12-2019 | Polycystic Kidney Disease | Research article
Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model
Published in: BMC Nephrology | Issue 1/2019
Login to get access